4D Molecular Therapeutics grants 21,800 restricted stock units to new employee

FDMT•2026-11-13

4D Molecular Therapeutics granted 21,800 restricted stock units to one new non-executive employee on November 10, 2026, under its amended 2025 Employment Inducement Award Plan.

1. Equity award

4D Molecular Therapeutics granted 21,800 restricted stock units to one new non-executive employee on November 10, 2026. The award was made under the company's amended 2025 Employment Inducement Award Plan.

4D Molecular Therapeutics grants 21,800 restricted stock units to new employee

1. Equity award

Related News

Evofem swings to Q3 net income of $1 million

Yiren Digital director Tina Lin-chi Ju resigns effective Nov. 12, 2026

PG&E director Mark E. Ferguson III reports disposal of $114,685.6152 in common shares

BeyondSpring swings to Q3 net income of $50.49 million

Navient Holdings director Frederick Arnold retires, effective immediately